North China Pharmaceutical Company.Ltd (SHA:600812)

China flag China · Delayed Price · Currency is CNY
5.71
+0.07 (1.24%)
Apr 8, 2026, 3:00 PM CST
Market Cap9.80B -8.2%
Revenue (ttm)9.79B +0.9%
Net Income183.03M +130.6%
EPS0.11 +113.5%
Shares Out1.72B
PE Ratio53.89
Forward PEn/a
Dividend0.03 (0.53%)
Ex-Dividend Daten/a
Volume45,443,648
Average Volume30,311,414
Open5.67
Previous Close5.64
Day's Range5.58 - 5.80
52-Week Range5.01 - 7.46
Beta0.43
RSI57.16
Earnings DateApr 18, 2026

About SHA:600812

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China and internationally. The company primarily offers anti-infective drugs, biotechnology drugs, cardiovascular cerebrovascular, immunomodulators, and vitamins and health products. It also provides chemical pharmaceuticals; and biological, agricultural, and veterinary drugs. North China Pharmaceutical Company.Ltd was founded in 1992 and is headquartered in Shijiazhuang, China. [Read more]

Sector Healthcare
Founded 1992
Employees 10,000
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600812
Full Company Profile

Financial Performance

In 2024, SHA:600812's revenue was 9.87 billion, a decrease of -2.48% compared to the previous year's 10.12 billion. Earnings were 126.99 million, an increase of 2496.79%.

Financial Statements